Acute kidney injury due to volume depletion has been reported in postmarketing reports occurring in patients who experienced nausea, vomiting, or diarrhea, leading to dehydration
The Phase 2 trial did show that gradual titration significantly reduces GI side effects
Ask about concentration, formulation, storage, dosing device, shipping, and contact information
Key strategies for minimizing the impact and severity of GI AEs associated with GLP-1 RA therapy include: Educational initiatives directed at both healthcare providers and patients Implementing different dose escalation schedules to improve patient adherence and overall outcomes in weight management treatment Understanding the pharmacokinetics of low dose initiation and gradual increase to the target dose to optimize treatment results Balancing the initial dosing with the achievement of target doses requires careful consideration and monitoring
Yes, GLP-1 therapy works best when paired with healthy eating habits
The functional role of the T1R family of receptors in sweet taste and feeding